Dogwood Therapeutics, INC. (DWTX) SEC Filings — 2024
24 SEC filings for Dogwood Therapeutics, INC. (DWTX) in 2024.
Filings
- Dogwood Therapeutics Files 8-K/A Amendment — 8-K/A · Dec 18, 2024
- Dogwood Therapeutics Faces Delisting Concerns — 8-K · Nov 21, 2024
- Dogwood Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 8, 2024
- Dogwood Therapeutics Files 8-K on Financials — 8-K · Nov 7, 2024
- Dogwood Therapeutics Files 8-K — 8-K · Oct 30, 2024
- CK Life Sciences Discloses Stake in Virios Therapeutics — SC 13D · Oct 15, 2024
- Virios Therapeutics Acquires 03 Life Sciences — 8-K · Oct 7, 2024
- Virios Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 9, 2024
- Virios Therapeutics Files 8-K — 8-K · Aug 8, 2024
- Virios Therapeutics Reports on Shareholder Vote — 8-K · Jun 20, 2024
- Virios Therapeutics Faces Delisting Notice — 8-K · Jun 12, 2024
- Virios Therapeutics Enters Material Definitive Agreement — 8-K · May 20, 2024
- Virios Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Virios Therapeutics Files 8-K on Financials — 8-K · May 9, 2024
- Virios Therapeutics Faces Delisting Concerns — 8-K · May 7, 2024
- Virios Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Virios Therapeutics Files 10-K/A Amendment — 10-K/A · Mar 8, 2024
- Virios Therapeutics Files 8-K on Security Holder Vote — 8-K · Mar 6, 2024
- Virios Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 1, 2024
- Virios Therapeutics Files 8-K on Financials — 8-K · Feb 29, 2024
- Virios Therapeutics Reports Officer/Director Changes, Compensation — 8-K · Feb 27, 2024
- Virios Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Virios Therapeutics seeks shareholder approval for a reverse stock split to fund Phase 2 development of IMC-2 for Long-COVID. — DEF 14A · Feb 2, 2024
- Virios Therapeutics Files Administrative 8-K; No New Material Events — 8-K · Jan 3, 2024